{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:05:09Z","timestamp":1792854309935,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08683-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:41:25Z","timestamp":1759239685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic value of systemic inflammation markers in early stage non-small cell lung cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Tevfik Ilker","family":"Akcam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Kayahan","family":"Tekneci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutsal","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhmus","family":"Cuhatutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berker","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Metin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Cansever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celal Bugra","family":"Sezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan Can","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necati","family":"Citak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Samancilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak","family":"Gorusun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Sami","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilgaz","family":"Dogusoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"3","key":"8683_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"8683_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/annonc\/mdv560","volume":"27","author":"T Donnem","year":"2016","unstructured":"Donnem, T. et al. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Ann. Oncol. 27 (2), 226\u2013232 (2016).","journal-title":"Ann. Oncol."},{"issue":"3","key":"8683_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jtho.2016.11.2216","volume":"12","author":"J Shin","year":"2017","unstructured":"Shin, J. et al. Prognostic impact of newly proposed M descriptors in TNM classification of Non-Small cell lung Cancer. J. Thorac. Oncol. 12 (3), 520\u2013528 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"8683_CR4","doi-asserted-by":"crossref","unstructured":"Carpagnano, G. E. et al. Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8. Bmc Cancer. 11, 226 (2011).","DOI":"10.1186\/1471-2407-11-226"},{"key":"8683_CR5","doi-asserted-by":"crossref","unstructured":"Lu, C. H. et al. vol 37, pg 6327,. USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2\/TRAF3 complex formation Oncogene. 2019;38(28):5742-3. (2018).","DOI":"10.1038\/s41388-019-0831-5"},{"issue":"11","key":"8683_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer. 13 (11), 759\u2013771 (2013).","journal-title":"Nat. Rev. Cancer"},{"issue":"9255","key":"8683_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill, F. & Mantovani, A. Inflammation and cancer: back to virchow?? Lancet 357 (9255), 539\u2013545 (2001).","journal-title":"Lancet"},{"issue":"6","key":"8683_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140 (6), 883\u2013899 (2010).","journal-title":"Cell"},{"issue":"3","key":"8683_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5606\/tgkdc.dergisi.2022.21217","volume":"30","author":"AK Tekneci","year":"2022","unstructured":"Tekneci, A. K. et al. Relationship between survival and erythrocyte sedimentation rate in patients operated for lung cancer. Turk. Gogus Kalp Dama. 30 (3), 381\u2013388 (2022).","journal-title":"Turk. Gogus Kalp Dama"},{"issue":"1","key":"8683_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"JL Ethier","year":"2017","unstructured":"Ethier, J. L. et al. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 19 (1), 2 (2017).","journal-title":"Breast Cancer Res."},{"issue":"30","key":"8683_CR11","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2217\/fon-2020-0423","volume":"16","author":"A Li","year":"2020","unstructured":"Li, A. et al. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases. Future Oncol. 16 (30), 2433\u20132444 (2020).","journal-title":"Future Oncol."},{"issue":"2","key":"8683_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/bjc.2013.346","volume":"109","author":"G Absenger","year":"2013","unstructured":"Absenger, G. et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Brit J. Cancer. 109 (2), 395\u2013400 (2013).","journal-title":"Brit J. Cancer"},{"issue":"6","key":"8683_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3892\/ol.2024.14385","volume":"27","author":"Z Su","year":"2024","unstructured":"Su, Z. et al. Pan\u2013immune\u2013inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma. Oncol. Lett. 27 (6), 252 (2024).","journal-title":"Oncol. Lett."},{"key":"8683_CR14","doi-asserted-by":"publisher","first-page":"830138","DOI":"10.3389\/fonc.2022.830138","volume":"12","author":"F Lin","year":"2022","unstructured":"Lin, F. et al. Pan-Immune-Inflammation value: A new prognostic index in operative breast Cancer. Front. Oncol. 12, 830138 (2022).","journal-title":"Front. Oncol."},{"key":"8683_CR15","doi-asserted-by":"publisher","first-page":"996844","DOI":"10.3389\/fsurg.2022.996844","volume":"9","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Pan-immune-inflammation value is associated with the clinical stage of colorectal cancer. Front. Surg. 9, 996844 (2022).","journal-title":"Front. Surg."},{"key":"8683_CR16","doi-asserted-by":"crossref","unstructured":"Cao, W. et al. Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: a meta-analysis. Cancer Med. 12 (6), 7065-7076 (2022).","DOI":"10.1002\/cam4.5505"},{"issue":"4","key":"8683_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MCP.0b013e32819f8f06","volume":"13","author":"AK Greenberg","year":"2007","unstructured":"Greenberg, A. K. & Lee, M. S. Biomarkers for lung cancer: clinical uses. Curr. Opin. Pulm Med. 13 (4), 249\u2013255 (2007).","journal-title":"Curr. Opin. Pulm Med."},{"issue":"9","key":"8683_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00595-007-3516-6","volume":"37","author":"I Yoshino","year":"2007","unstructured":"Yoshino, I. & Maehara, Y. Impact of smoking status on the biological behavior of lung cancer. Surg. Today. 37 (9), 725\u2013734 (2007).","journal-title":"Surg. Today"},{"issue":"5","key":"8683_CR19","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3892\/ol.2013.1566","volume":"6","author":"F Tas","year":"2013","unstructured":"Tas, F., Ciftci, R., Kilic, L. & Karabulut, S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol. Lett. 6 (5), 1507\u20131513 (2013).","journal-title":"Oncol. Lett."},{"issue":"2","key":"8683_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10555-010-9223-6","volume":"29","author":"DG DeNardo","year":"2010","unstructured":"DeNardo, D. G., Andreu, P. & Coussens, L. M. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 29 (2), 309\u2013316 (2010).","journal-title":"Cancer Metastasis Rev."},{"issue":"7","key":"8683_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00262-008-0631-1","volume":"58","author":"CC Johansson","year":"2009","unstructured":"Johansson, C. C. et al. Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunol. Immunother. 58 (7), 1085\u20131094 (2009).","journal-title":"Cancer Immunol. Immunother"},{"issue":"Suppl 3","key":"8683_CR22","doi-asserted-by":"publisher","first-page":"S1324","DOI":"10.1245\/s10434-015-4735-5","volume":"22","author":"Y Takahashi","year":"2015","unstructured":"Takahashi, Y. et al. Prognostic significance of preoperative Neutrophil-Lymphocyte ratios in patients with stage I Non-small cell lung Cancer after complete resection. Ann. Surg. Oncol. 22 (Suppl 3), S1324\u2013S1331 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"8683_CR23","doi-asserted-by":"publisher","first-page":"e7232","DOI":"10.7717\/peerj.7232","volume":"7","author":"Z Lohinai","year":"2019","unstructured":"Lohinai, Z. et al. Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer. PeerJ 7, e7232 (2019).","journal-title":"PeerJ"},{"issue":"3","key":"8683_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.21037\/tlcr.2019.06.10","volume":"8","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis. Transl Lung Cancer Res. 8 (3), 214\u2013226 (2019).","journal-title":"Transl Lung Cancer Res."},{"key":"8683_CR25","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.1038\/srep12493","volume":"5","author":"XB Gu","year":"2015","unstructured":"Gu, X. B., Tian, T., Tian, X. J. & Zhang, X. J. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. Sci. Rep. 5, 12493 (2015).","journal-title":"Sci. Rep."},{"issue":"1","key":"8683_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12890-021-01446-1","volume":"21","author":"R Ramos","year":"2021","unstructured":"Ramos, R. et al. Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery. BMC Pulm Med. 21 (1), 75 (2021).","journal-title":"BMC Pulm Med."},{"issue":"6","key":"8683_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.21037\/tlcr.2019.11.16","volume":"8","author":"H Mandaliya","year":"2019","unstructured":"Mandaliya, H., Jones, M., Oldmeadow, C. & Nordman, I. I. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. 8 (6), 886\u2013894 (2019).","journal-title":"Transl Lung Cancer Res."},{"issue":"12","key":"8683_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.21037\/atm-21-2120","volume":"9","author":"B Zhai","year":"2021","unstructured":"Zhai, B. et al. Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery. Ann. Transl Med. 9 (12), 976 (2021).","journal-title":"Ann. Transl Med."},{"key":"8683_CR29","doi-asserted-by":"publisher","first-page":"22618","DOI":"10.1038\/srep22618","volume":"6","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci. Rep. 6, 22618 (2016).","journal-title":"Sci. Rep."},{"key":"8683_CR30","doi-asserted-by":"crossref","unstructured":"Guven, D. C. et al. The association between the Pan-Immune-Inflammation value and Cancer prognosis: A systematic review and Meta-Analysis. Cancers (Basel). 14 (11), 2675 (2022).","DOI":"10.3390\/cancers14112675"},{"issue":"7","key":"8683_CR31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1158\/1055-9965.EPI-14-0146","volume":"23","author":"AJ Templeton","year":"2014","unstructured":"Templeton, A. J. et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 23 (7), 1204\u20131212 (2014).","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08683-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:41:28Z","timestamp":1759239688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08683-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8683"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08683-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We obtained written informed consent from each patient and conducted the study in accordance with the principles of the Declaration of Helsinki. Ege University Medical Research Ethics Committee granted approval for the study (No: 23-12T\/20).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}}],"article-number":"33886"}}